Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER: TP-122A for Ventilator-Associated Pneumonia
NCT06370598Phase 2Not yet recruiting
- Sponsor
- TechnoPhage
- Start
- Sep 2024
- Primary completion
- May 2025
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of TP-122A in ventilator-associated pneumonia (VAP), sponsored by TechnoPhage. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
TP-122A
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT06370598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06370598.